{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:11:58Z","timestamp":1684415518858},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2002,3]]},"DOI":"10.1038\/sj.bjc.6600200","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T15:07:30Z","timestamp":1031152050000},"page":"870-878","source":"Crossref","is-referenced-by-count":6,"title":["Axillary node status in breast cancer patients prior to surgery by imaging with Tc-99m humanised anti-PEM monoclonal antibody, hHMFG1"],"prefix":"10.1038","volume":"86","author":[{"given":"A R","family":"Al-Yasi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M J","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Ellison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Granowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S J","family":"Mather","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C A","family":"Wells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K E","family":"Britton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2002,3,12]]},"reference":[{"key":"BF6600200_CR1","first-page":"663","volume":"25","author":"PD Acton","year":"1998","unstructured":"Acton, PD & Friston, KJ (1998). Statistical parametric mapping in functional neuroimaging: beyond PET and fMRI activation studies. Eur J Nucl Med, 25: 663\u2013667.","journal-title":"Eur J Nucl Med"},{"key":"BF6600200_CR2","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/bjc.1993.131","volume":"67","author":"V Apostolopoulos","year":"1993","unstructured":"Apostolopoulos, V, Xing, PX, Trapani, JA & McKenzie, IF (1993). Production of anti-breast cancer monoclonal antibodies using a glutathione-S-transferase-MUC1 bacterial fusion protein. Br J Cancer, 67: 713\u2013720.","journal-title":"Br J Cancer"},{"key":"BF6600200_CR3","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1093\/jnci\/88.17.1204","volume":"88","author":"N Avril","year":"1996","unstructured":"Avril, N, Dose, J, Janicke, F, Ziegler, S, Romer, W, Weber, W, Herz, M, Nauman, W, Graeff, H & Schwaiger, M (1996). Assessment of axillary lymph node involvement in breast cancer. Patients with positron emission tomography using radiolabeled 2 (fluorine 18)-fluoro-2 deoxy-D-glucose. J Natl Cancer Inst, 88: 1204\u20131209.","journal-title":"J Natl Cancer Inst"},{"key":"BF6600200_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/bjc.1998.21","volume":"77","author":"L Biassoni","year":"1998","unstructured":"Biassoni, L, Granowska, M, Carroll, MJ, Mather, SJ, Howell, R, Ellison, D, MacNeil, FA, Wells, CA, Carpenter, R & Britton, KE (1998). Tc-99m labelled SM3 in the pre-operative evaluation of axillary lymph nodes and primary breast cancer with change detection statistical processing as an aid to tumour detection. Br J Cancer, 77: 131\u2013138.","journal-title":"Br J Cancer"},{"key":"BF6600200_CR5","first-page":"693","volume":"8","author":"E Bombardieri","year":"1996","unstructured":"Bombardieri, E, Crippa, F, Maffioli, L, Draisma, A, Chiti, A, Agresti, R & Greco, M (1996). Axillary lymph node metastases detection with nuclear medicine approaches in patients with newly diagnosed breast cancer: can PET with 18F-FDG be considered as the best methods? Int J Oncol, 8: 693\u2013699.","journal-title":"Int J Oncol"},{"key":"BF6600200_CR6","first-page":"247","volume":"6","author":"KE Britton","year":"1987","unstructured":"Britton, KE & Granowska, M (1987). Radioimmunoscintigraphy in tumour identification. Cancer Surv, 6: 247\u2013267.","journal-title":"Cancer Surv"},{"key":"BF6600200_CR7","first-page":"5476","volume":"47","author":"J Burchell","year":"1987","unstructured":"Burchell, J, Gendler, S, Taylor-Papadimetriou, J, Girling, A, Lewis, A, Millis, R & Lamport, D (1987). Development and characterisation of Breast cancer reactive monoclonal antibodies directed to the coreprotein of the human milk mucin. Cancer Res, 47: 5476\u20135482.","journal-title":"Cancer Res"},{"key":"BF6600200_CR8","first-page":"155","volume":"2","author":"J Burchell","year":"1993","unstructured":"Burchell, J & Taylor-Papadimitriou, J (1993). Effect of modification of the carbohydrate side chains in the reactivity of antibodies with core protein epitopes. Epithel Cell Biol, 2: 155\u2013162.","journal-title":"Epithel Cell Biol"},{"key":"BF6600200_CR9","first-page":"4","volume":"39","author":"F Crippa","year":"1998","unstructured":"Crippa, F, Agresti, R, Seregni, E, Greco, M, Pascali, C, Bogni, A, Chiesa, C, De Sanctis, V, Delledonne, V, Salvadori, B, Leutner, M & Bombardieri, E (1998). Prospective evaluation of F18-FDG PET in presurgical staging of the axilla in breast cancer. J Nucl Med, 39: 4\u20138.","journal-title":"J Nucl Med"},{"key":"BF6600200_CR10","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S0140-6736(82)90046-0","volume":"ii:","author":"AA Epenetos","year":"1982","unstructured":"Epenetos, AA, Britton, KE, Mather, S, Shepherd, J, Granowska, M, Taylor-Papadimitriou, J, Nimmon, CC, Durbin, H, Hawkins, LR, Malpas, JS & Bodmer, WF (1982). Targeting of Iodine-123-labeled tumour associated monoclonal antibodies to ovarian, breast and gastrointestinal tumours. Lancet, ii:: 999\u20131005.","journal-title":"Lancet"},{"key":"BF6600200_CR11","doi-asserted-by":"publisher","first-page":"4181","DOI":"10.1073\/pnas.88.10.4181","volume":"88","author":"SD Gorman","year":"1991","unstructured":"Gorman, SD, Clark, MR, Routledge, EG, Cobbold, SP & Waldmann, H (1991). Reshaping a therapeutic CD4 antibody. Proc Natl Acad Sci USA, 88: 4181\u20134183.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF6600200_CR12","first-page":"594","volume":"29","author":"M Granowska","year":"1988","unstructured":"Granowska, M, Nimmon, CC, Britton, KE, Crowther, M, Mather, SJ, Slevin, ML & Shepherd, JH (1988). Kinetic analysis and Probability Mapping applied to the detection of Ovarian Cancer by Radioimmunoscintigraphy. J Nucl Med, 29: 594\u2013607.","journal-title":"J Nucl Med"},{"key":"BF6600200_CR13","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/321522a0","volume":"321","author":"PT Jones","year":"1986","unstructured":"Jones, PT, Dear, PH, Foote, J, Neuberger, MS & Winter, G (1986). Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature, 321: 522\u2013525.","journal-title":"Nature"},{"key":"BF6600200_CR14","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1056\/NEJM199810013391401","volume":"339","author":"D Krag","year":"1998","unstructured":"Krag, D, Weaver, D, Ashikaga, T, Moffat, F, Klimberg, VS, Shriver, C, Feldman, S, Kusminsky, R, Gadd, M, Kuhn, J, Harlow, S & Beitsch, P (1998). The sentinel node in breast cancer- a multicentre validation study. N Engl J Med, 339: 941\u2013946.","journal-title":"N Engl J Med"},{"key":"BF6600200_CR15","first-page":"692","volume":"31","author":"S Mather","year":"1990","unstructured":"Mather, S & Ellison, D (1990). Reduction mediated Technetium-99m labelling of monoclonal antibodies. J Nucl Med, 31: 692\u2013697.","journal-title":"J Nucl Med"},{"key":"BF6600200_CR16","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1126\/science.2451287","volume":"239","author":"L Riechmann","year":"1988","unstructured":"Riechmann, L, Clark, M, Waldmann, H & Winter, G (1988). Reshaping human antibodies: grafting antilysozyme activity. Science, 239: 1534","journal-title":"Science"},{"key":"BF6600200_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-57151-0","volume-title":"Lymphatic Metastasis and Sentinel Lymphonodectomy","author":"PM Schlag","year":"2000","unstructured":"Schlag, PM & Veronesi, U (2000). Recent results in cancer research. In Lymphatic Metastasis and Sentinel Lymphonodectomy, Berlin: Springer"},{"key":"BF6600200_CR18","volume-title":"Physics in Nuclear Medicine","author":"JA Sorenson","year":"1987","unstructured":"Sorenson, JA & Phelps, ME (1987). In Physics in Nuclear Medicine, 2nd ednPhiladelphia: W B Saunders Co"},{"key":"BF6600200_CR19","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/BF01731842","volume":"23","author":"M Stalteri","year":"1996","unstructured":"Stalteri, M & Mather, SJ (1996). Technetium-99m labelling of the anti-tumour antibody PR1A3 by photoactivation. Eur J Nucl Med, 23: 178\u2013187.","journal-title":"Eur J Nucl Med"},{"key":"BF6600200_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/ijc.2910280104","volume":"28","author":"J Taylor-Papadimitriou","year":"1981","unstructured":"Taylor-Papadimitriou, J, Peterson, JA, Arklie, J, Burchell, J, Ceriani, RL & Bodmer, WF (1981). Monoclonal antibodies to epithelium specific components of human milk fat globule: Production and reaction with cells in culture. Int J Cancer, 28: 17\u201321.","journal-title":"Int J Cancer"},{"key":"BF6600200_CR21","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1007\/BF01249621","volume":"23","author":"CI Utech","year":"1996","unstructured":"Utech, CI, Young, CS & Winter, PF (1996). Prospective evaluation of fluorine-18 fluorodeoxyglucose positron emission tomography in staging of the axilla related to surgery and immunocytochemistry. Eur J Nucl Med, 23: 1588\u20131593.","journal-title":"Eur J Nucl Med"},{"key":"BF6600200_CR22","first-page":"364","volume":"78","author":"M Verhoeyen","year":"1993","unstructured":"Verhoeyen, M, Saunders, JA, Price, MR, Marugg, JD, Briggs, S, Broderick, EL, Eida, SJ, Mooren, AT & Badley, RA (1993). Construction of a reshaped HMFG1 antibody and comparison of its fine specificitywith that of the parent mouse antibody. Immunology, 78: 364\u2013370.","journal-title":"Immunology"},{"key":"BF6600200_CR23","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1016\/S0140-6736(97)01004-0","volume":"349","author":"U Veronesi","year":"1997","unstructured":"Veronesi, U, Paganelli, G, Galimberti, V, Viale, G, Zurrida, S, Bedoni, M, Costa, A, de Cicco, C, Geraghty, JG, Luini, A, Sacchini, V & Veronesi, P (1997). Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet, 349: 1864\u20131867.","journal-title":"Lancet"},{"key":"BF6600200_CR24","first-page":"981","volume":"32","author":"RL Wahl","year":"1991","unstructured":"Wahl, RL, Cody, RL & August, D (1991). Initial evaluation of FDG PET for the staging of the axilla in newly-diagnosed breast carcinoma patients. J Nucl Med, 32: 981\u2013984.","journal-title":"J Nucl Med"},{"key":"BF6600200_CR25","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1054\/bjoc.2000.1431","volume":"83","author":"RW Wilkinson","year":"2000","unstructured":"Wilkinson, RW, Ross, EL, Lee-MacAry, AE, Laylor, R, Burchell, J, Taylor-Papadimitriou, J & Snary, D (2000). A transgenic mouse model for tumour immunotherapy: induction of an anti-idiotype response to human MUC1. Br J Cancer, 83: 1202\u20131208.","journal-title":"Br J Cancer"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6600200.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6600200","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6600200.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:41:37Z","timestamp":1684413697000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6600200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["BF6600200"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6600200","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,3]]}}}